Proficio Capital Partners LLC Buys Shares of 11,696 Omega Healthcare Investors, Inc. (NYSE:OHI)

Proficio Capital Partners LLC bought a new stake in Omega Healthcare Investors, Inc. (NYSE:OHI) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 11,696 shares of the real estate investment trust’s stock, valued at approximately $443,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of OHI. Daiwa Securities Group Inc. grew its holdings in shares of Omega Healthcare Investors by 317.7% during the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock worth $160,739,000 after purchasing an additional 3,003,845 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Omega Healthcare Investors by 328.6% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,661,964 shares of the real estate investment trust’s stock worth $67,642,000 after purchasing an additional 1,274,238 shares during the last quarter. FMR LLC grew its holdings in shares of Omega Healthcare Investors by 9.9% during the third quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock worth $171,625,000 after purchasing an additional 380,626 shares during the last quarter. Franklin Resources Inc. grew its holdings in shares of Omega Healthcare Investors by 441.4% during the third quarter. Franklin Resources Inc. now owns 429,993 shares of the real estate investment trust’s stock worth $17,177,000 after purchasing an additional 350,570 shares during the last quarter. Finally, Parallax Volatility Advisers L.P. grew its holdings in shares of Omega Healthcare Investors by 115.9% during the third quarter. Parallax Volatility Advisers L.P. now owns 34,982 shares of the real estate investment trust’s stock worth $1,424,000 after purchasing an additional 254,471 shares during the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

Shares of OHI opened at $37.59 on Tuesday. Omega Healthcare Investors, Inc. has a 52-week low of $29.66 and a 52-week high of $44.42. The company has a debt-to-equity ratio of 1.02, a quick ratio of 7.07 and a current ratio of 7.07. The business’s 50 day moving average price is $37.11 and its two-hundred day moving average price is $39.00. The firm has a market cap of $10.59 billion, a PE ratio of 24.25, a price-to-earnings-growth ratio of 1.09 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.33. Omega Healthcare Investors had a return on equity of 9.71% and a net margin of 38.65%. On average, equities analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Monday, February 10th were given a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 7.13%. The ex-dividend date of this dividend was Monday, February 10th. Omega Healthcare Investors’s payout ratio is 172.90%.

Wall Street Analyst Weigh In

OHI has been the topic of several research reports. Mizuho boosted their price target on Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a “neutral” rating in a report on Thursday, December 5th. Wells Fargo & Company reduced their price target on Omega Healthcare Investors from $43.00 to $41.00 and set an “overweight” rating on the stock in a report on Monday. JMP Securities restated a “market perform” rating on shares of Omega Healthcare Investors in a report on Friday, February 7th. Royal Bank of Canada upped their target price on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a report on Monday, November 11th. Finally, BMO Capital Markets upgraded Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 target price on the stock in a report on Monday, December 9th. Five equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $41.44.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.